Pooled safety analysis of long-term, once-daily multimatrix mesalazine use

被引：0
|
作者：
Da Silva Sanchez, S. [1 ]
Wan, H. [2 ]
Streck, P. [3 ]
Willshire, D. [4 ]
Raskin, J. B. [5 ]
机构：
[1] Shire, Med Affairs, Brussels, Belgium
[2] Shire, Biostat, Wayne, PA USA
[3] Shire, Global Clin Dev, Wayne, PA USA
[4] Shire, Med Affairs, N Ryde, NSW, Australia
[5] Univ Miami Hlth Syst, Gastroenterol & Internal Med, Miami, FL USA
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P538
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [31] Pooled clinical trial analysis of MMX mesalazine safety: Focus on 4.8 g/d dose long-term exposure
    Sanchez, S. Da Silva
    Palmen, M.
    Streck, P.
    Inglis, S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S230 - S230
  • [32] Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis
    Schreiber, Stefan
    Hanauer, Stephen B.
    Sandborn, William J.
    Barrett, Karen
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (09): : 1274 - 1281
  • [33] LOW-DOSES OF CAPTOPRIL IN ASSOCIATION WITH ONCE-DAILY OR TWICE-DAILY HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION - LONG-TERM EFFICACY AND SAFETY
    COSTA, FV
    BORGHI, C
    AMBROSIONI, E
    MAGNANI, B
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1984, 36 (01): : 181 - 187
  • [34] Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
    Zakko, Salam F.
    Gordon, Glenn L.
    Murthy, Uma
    Sedghi, Shahriar
    Pruitt, Ronald
    Barrett, Andrew C.
    Bortey, Enoch
    Paterson, Craig
    Forbes, William P.
    Lichtenstein, Gary R.
    POSTGRADUATE MEDICINE, 2016, 128 (03) : 273 - 281
  • [35] Efficacy and Safety of Once-Daily Everolimus With Minimized Once-Daily Tacrolimus After Liver Transplantation
    De Simone, Paolo
    Carrai, Paola
    Precisi, Arianna
    Coletti, Laura
    Campani, Daniela
    Filipponi, Franco
    TRANSPLANTATION, 2015, 99 : 274 - 275
  • [36] Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
    Jeon, Seong Ran
    INTESTINAL RESEARCH, 2018, 16 (02) : 163 - 165
  • [37] Effectiveness and safety of once-daily aminoglycosides: A meta-analysis
    FerriolsLisart, R
    AlosAlminana, M
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (10) : 1141 - 1150
  • [38] Efficacy and Safety of Once-Daily Everolimus With Minimized Once-Daily Tacrolimus After Liver Transplantation
    De Simone, P.
    Carrai, P.
    Coletti, L.
    Precisi, A.
    Campani, D.
    Filipponi, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [39] Long-term efficacy and safety with deferasirox (Exjade®, ICL670), a once-daily oral iron chelator, in pediatric patients
    Piga, Antonio
    Vichinsky, Elliott
    Forni, Gian Luca
    Kilinc, Yurdanur
    Maseruka, Henry
    Kattamis, Antonios
    BLOOD, 2007, 110 (11) : 815A - 815A
  • [40] Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan
    Seino, Yutaka
    Yabe, Daisuke
    Takami, Akane
    Niemoeller, Elisabeth
    Takagi, Hiroki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1304 - 1309
12345